Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
17.92
+3.61 (25.23%)
At close: Jan 9, 2026, 4:00 PM EST
19.66
+1.74 (9.71%)
After-hours: Jan 9, 2026, 7:59 PM EST
Intelligent Bio Solutions Revenue
Intelligent Bio Solutions had revenue of $1.11M in the quarter ending September 30, 2025, with 27.46% growth. This brings the company's revenue in the last twelve months to $3.29M, up 3.26% year-over-year. In the fiscal year ending June 30, 2025, Intelligent Bio Solutions had annual revenue of $3.05M, down -1.90%.
Revenue (ttm)
$3.29M
Revenue Growth
+3.26%
P/S Ratio
3.52
Revenue / Employee
$59,855
Employees
55
Market Cap
21.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.05M | -59.25K | -1.90% |
| Jun 30, 2024 | 3.11M | 1.85M | 147.58% |
| Jun 30, 2023 | 1.26M | 819.73K | 187.52% |
| Jun 30, 2022 | 437.15K | -1.54M | -77.93% |
| Jun 30, 2021 | 1.98M | 1.79M | 949.30% |
| Jun 30, 2020 | 188.74K | - | - |
| Jun 30, 2019 | - | - | - |
| Jun 30, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
INBS News
- 7 days ago - Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 9 days ago - Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 9 days ago - Intelligent Bio Stock Doubles On New Manufacturing Deal Promising Major Cost Cuts - Benzinga
- 9 days ago - Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins - GlobeNewsWire
- 22 days ago - Intelligent Bio Solutions Announces Strategic Partnership with Vlepis, Provider of Advanced Sensing and Wearable Patch Technologies, to Drive Innovation in Non-Invasive Screening and Consumer Health Monitoring - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions Inc. Announces Reverse Stock Split - GlobeNewsWire
- 7 weeks ago - Intelligent Bio Solutions to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference on December 2-3, 2025 - Newsfile Corp
- 2 months ago - Intelligent Bio Solutions Reports Fiscal 2026 First Quarter Financial Results and Operational Highlights, Delivering Record Revenue Growth - GlobeNewsWire